Tuesday, October 17, 2017
 
 
Company News: Page (1) of 1 - 09/21/17 Email this story to a friend. email article Print this page (Article printing at MyDmn.com).print page facebook
CORRECTING and REPLACING Synergy Pharmaceuticals to Present at Upcoming September Investor Conferences
By Business Wire

NEW YORK--(BUSINESS WIRE)--In the release dated September 6, 2017, the presentation date and time for the Cantor Fitzgerald Global Healthcare Conference should be changed to Wednesday, September 27, 2017 at 9:45 a.m. Eastern Time (instead of Monday, September 25, 2017 at 10:20 a.m. Eastern Time).


The corrected release reads:

SYNERGY PHARMACEUTICALS TO PRESENT AT UPCOMING SEPTEMBER INVESTOR CONFERENCES

Synergy Pharmaceuticals Inc. (NASDAQ: SGYP) today announced that the company will present corporate updates at three upcoming investor conferences in New York City during September:


Rodman & Renshaw 19th Annual Global Investment Conference on Monday, September 11, 2017 at 9:35 a.m. Eastern Time.

Ladenburg Thalmann 2017 Healthcare Conference on Tuesday, September 26, 2017 at 10:30 a.m. Eastern Time.

Cantor Fitzgerald Global Healthcare Conference on Wednesday, September 27, 2017 at 9:45 a.m. Eastern Time.

A live webcast of the presentations will be accessible through the Investor Relations section of the companys website at www.synergypharma.com. A replay of the webcast will be available on Synergys website for 90 days following each conference.

About Synergy Pharmaceuticals Inc.

Synergy is a biopharmaceutical company focused on the development and commercialization of novel gastrointestinal (GI) therapies. The company has pioneered discovery, research and development efforts on analogs of uroguanylin, a naturally occurring and endogenous human GI peptide, for the treatment of GI diseases and disorders. Synergys proprietary GI platform includes one commercial product TRULANCE (plecanatide) and a second lead product candidate, dolcanatide. For more information, please visit www.synergypharma.com.


Contacts

Synergy Pharmaceuticals Inc.
Gem Hopkins, 212-584-7610
VP, Investor Relations and Corporate Communications
[email protected]


Page: 1


 





About Video Based Tutorials - Contact Us - Advertise With Us - Privacy Guidelines